Atrial Fibrillation Screening Post Ischemic Cerebrovascular Events
Recruiting
N/A
Interventional Study
Ischemic Stroke
TIA
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 70 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 3,300 (estimated)
- Sponsor
- Karolinska Institutet · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Stroke is one of the leading causes behind death and permanent disability in adults. Atrial fibrillation (AF) is the most common clinical arrhythmia and its prevalence is steeply increasing with age. Atrial fibrillation is associated with a manifold increase in the risk for stroke.
It is considered important to investigate the heart rhythm in stroke survivors without previously known AF, because …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients aged ≥ 70 years
* A diagnosis of ischemic stroke or TIA within 14 days from inclusion.
Exclusion Criteria:
* Previously diagnosed atrial fibrillation
* Contraindication to oral anticoagulant treatment according to Summary of Product Characteristics.
* Indication for…
Contacts